KeyBanc analyst Donald Hooker maintained a Buy rating on Icon plc (NASDAQ: ICLR) today and set a price target of $157. The company’s shares closed yesterday at $145.50, close to its 52-week high of $150.18.
According to TipRanks.com, Hooker is a 5-star analyst with an average return of 16.6% and a 76.3% success rate. Hooker covers the Services sector, focusing on stocks such as PRA Health Sciences, Charles River Labs, and Syneos Health Inc.
Icon plc has an analyst consensus of Moderate Buy, with a price target consensus of $152.43.
See today’s analyst top recommended stocks >>
Based on Icon plc’s latest earnings release for the quarter ending June 30, the company reported a quarterly net profit of $71.87 million. In comparison, last year the company had a net profit of $64.82 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
ICON plc is a contract research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It operates through the following geographical segments: Ireland, Rest of Europe, United States, and Other.
